The uninsured rate declined sharply in 2014 and by nearly one-fifth to 16 percent of the population since the Patient Protection and Affordable Care Act went into effect, according to new figures.

Every year at this time, we write a series of articles on the voluntary market sales results for the prior year. This article is the first of three on this subject.

The leading group of U.S. cancer doctors created a scoring system for oncology drugs, awarding a zero for overall benefit to the $9,200-a-month regimen featuring Eli Lilly & Co.s Alimta.